In the August 15, 2008, issue of Clinical Cancer Research, (published online August 12) researchers from the University of Chicago Medical Center report that targeted radiation therapy had completely controlled all signs of cancer in 21 percent of patients who had five or fewer sites of metastatic disease.
The technique could also be applied after chemotherapy […]

continue reading from " Precisely targeted radiation therapy can eradicate limited cancer spread "

Health Discovery Corporation’s New Molecular Diagnostic Test for Prostate Cancer Successfully Performs at 90% Sensitivity and 97% Specificity in Double-Blind Clinical Trial
Results from Phase I, Phase II and Phase III double-blinded clinical validation studies now completed with prostate tissues obtained from multiple sites, including those tested in collaboration with MD Anderson Cancer Center, demonstrated a […]

continue reading from " New Prostate Cancer Test is Ready for Commercialization "

The Hormone deprivation therapy, also known as androgen depletion therapy, basically involves androgen depletion through chemical castration with drugs such as leuprolide and goserelin.
Prostate cancer patients who are prescribed these drugs often stay on them for the duration of their life, and the researchers have been documenting the potential adverse effects associated with their use.
New […]

continue reading from " Hormone therapy for prostate cancer may impair cognition "

In a study using laboratory animals, researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors.
The drugs blocked an enzyme and opened blood vessels to tumors but not normal brain. According to the researchers, these findings may have […]

continue reading from " Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study "

Scientists at the Institute of Cancer Research have come up with a miraculous new drug that can potentially save the lives of thousands of prostate cancer sufferers.
According to scientists, men with aggressive and incurable prostate cancer can gain years of life with abiraterone.
Abiraterone could potentially treat up to 80percent of patients with a deadly form […]

continue reading from " New ‘prostrate cancer drug’ raises hope "

Scientists say a new drug which treats aggressive prostate cancer is possibly the most significant development in the field for 70 years.
The new drug Abiraterone could they say potentially treat up to 80% of patients with a deadly form of the disease which is resistant to currently available chemotherapy.
Abiraterone works by blocking the hormones which […]

continue reading from " New drug for aggressive prostate cancer the best thing in 70 years "

A lot of doctors give androgen deprivation therapy without any evidence that it’s a good thing for early-stage prostate cancer. One of the reasons we’re in such a quagmire on prostate cancer is so many doctors have practiced medicine not supporting the clinical trials but just treating it the way they think they ought to […]

continue reading from " Hormone therapy rates no different than ‘watchful waiting’ in prostate cancer "

Hormone therapy is the second most-used treatment after surgery for early prostate cancer that hasn’t spread, although the drugs aren’t approved for that use, researchers said. The medicines can cause side effects such as hot flashes and impotence and have been associated with osteoporosis and diabetes.
Widely used hormone-blocking drugs failed to improve survival in older […]

continue reading from " Prostate cancer vaccines more potent with hormone therapy "

Scientists at Dana-Farber Cancer Institute report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they describe as a “powerhouse” that drives runaway cell growth.
They said that drugs are on their way to clinical testing, but is hard to predict when they might become available for clinical […]

continue reading from " Researchers identify promising cancer drug target in prostate tumors "

Researchers from Oregon Health and Science University have found a new chemotherapy drug that may help treat prostate cancer.
Sagopilone, a fully synthetic derivation, is a new class of drug that inhibits growth and the spread of malignant cell, similar to docetaxel, which has been the gold standard for this type of hormone independent prostate cancer.
This […]

continue reading from " New Chemo Drug May Help Treat Prostate Cancer "